Hikma Pharmaceuticals PLC (HIK) — Cash Flow-to-Debt Ratio
Hikma Pharmaceuticals PLC (HIK) has a Cash Flow-to-Debt Ratio of 0.05x as of June 2025, meaning its operating cash flow of GBX161.00 Million could theoretically repay 0% of its total liabilities (GBX3.00 Billion) in one year. Explore investment intensity of Hikma Pharmaceuticals PLC to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Hikma Pharmaceuticals PLC Cash Flow-to-Debt Ratio (2002–2024)
Historical debt coverage capacity for Hikma Pharmaceuticals PLC across 23 annual periods. Also explore Hikma Pharmaceuticals PLC total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Hikma Pharmaceuticals PLC (2002–2024)
Year-by-year debt coverage analysis for Hikma Pharmaceuticals PLC. For market capitalisation and broader financial context, see Hikma Pharmaceuticals PLC (HIK) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (GBX) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.20x | GBX564.00 Million | GBX2.81 Billion | ▼ -18.5% |
| 2023 | 0.25x | GBX608.00 Million | GBX2.47 Billion | ▲ +7.8% |
| 2022 | 0.23x | GBX530.00 Million | GBX2.32 Billion | ▼ -31.9% |
| 2021 | 0.33x | GBX638.00 Million | GBX1.91 Billion | ▲ +43.4% |
| 2020 | 0.23x | GBX464.00 Million | GBX1.99 Billion | ▼ -10.9% |
| 2019 | 0.26x | GBX472.00 Million | GBX1.80 Billion | ▲ +9.7% |
| 2018 | 0.24x | GBX430.00 Million | GBX1.80 Billion | ▲ +0.3% |
| 2017 | 0.24x | GBX443.00 Million | GBX1.86 Billion | ▲ +58.7% |
| 2016 | 0.15x | GBX293.00 Million | GBX1.95 Billion | ▼ -48.9% |
| 2015 | 0.29x | GBX366.00 Million | GBX1.25 Billion | ▼ -28.4% |
| 2014 | 0.41x | GBX425.00 Million | GBX1.03 Billion | ▲ +9.1% |
| 2013 | 0.38x | GBX337.00 Million | GBX895.00 Million | ▲ +82.4% |
| 2012 | 0.21x | GBX182.16 Million | GBX882.26 Million | ▲ +56.3% |
| 2011 | 0.13x | GBX102.64 Million | GBX777.01 Million | ▼ -65.2% |
| 2010 | 0.38x | GBX138.79 Million | GBX365.52 Million | ▲ +22.2% |
| 2009 | 0.31x | GBX105.52 Million | GBX339.46 Million | ▲ +92.0% |
| 2008 | 0.16x | GBX57.87 Million | GBX357.46 Million | ▲ +76.2% |
| 2007 | 0.09x | GBX43.12 Million | GBX469.38 Million | ▼ -57.6% |
| 2006 | 0.22x | GBX29.99 Million | GBX138.56 Million | ▼ -26.9% |
| 2005 | 0.30x | GBX32.71 Million | GBX110.48 Million | ▼ -8.7% |
| 2004 | 0.32x | GBX32.84 Million | GBX101.31 Million | ▲ +1.4% |
| 2003 | 0.32x | GBX18.35 Million | GBX57.39 Million | ▲ +4.3% |
| 2002 | 0.31x | GBX14.35 Million | GBX46.84 Million | — |